These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 114528)

  • 1. On the morphological evaluation of the neurovirulence safety of attenuated mumps virus strains in monkeys.
    Levenbuk IS; Nikolayeva MA; Chigirinsky AE; Ralf NM; Kozlov VG; Vardanyan NV; Sliopushkina VG; Kolomiets OL; Rukhamina ML; Grigoryeva LV
    J Biol Stand; 1979 Jan; 7(1):9-19. PubMed ID: 114528
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study on the neurovirulence of different vaccine strains of parotitis virus in monkeys.
    Rozina EE; Hilgenfeldt M
    Acta Virol; 1985 May; 29(3):225-30. PubMed ID: 2864823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of mumps virus invasiveness in monkeys.
    Rozina EE; Kaptsova TI; Sharova OK; Nikolaeva MA; Nesterova TP
    Acta Virol; 1984 Mar; 28(2):107-13. PubMed ID: 6145343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the neurovirulence test for mumps vaccines.
    Afzal MA; Marsden SA; Hull RM; Pipkin PA; Bentley ML; Minor PD
    Biologicals; 1999 Mar; 27(1):43-9. PubMed ID: 10441402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains.
    Rubin SA; Snoy PJ; Wright KE; Brown EG; Reeve P; Beeler JA; Carbone KM
    J Infect Dis; 1999 Aug; 180(2):521-5. PubMed ID: 10395874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unsuitability of the neurovirulence test for assessing the safety of vaccinal strains of the mumps virus].
    Smorodintsev AA
    Tr Inst Im Pastera; 1979; 53():101-3. PubMed ID: 262708
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of Leningrad-3 mumps vaccine virus neurovirulence in a neonatal rat model].
    Ignat'ev GM; Otrashevskaia EV; Rubin SA
    Vopr Virusol; 2011; 56(4):30-3. PubMed ID: 21899067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of a study of live mumps vaccine from strain L-3 produced by the Moscow research institute for viral preparations. Characteristics of the vaccine].
    Kaptsova TI; Alekseeva AK; Gordienko NM; Rozina EE; Ermakova MN
    Vopr Virusol; 1976; (6):674-85. PubMed ID: 829008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on live attenuated mumps virus vaccine. 1. Attenuation of mumps virus by serial passage in the chorioallantoic cavity of developing chick embryos and field trials by the inhalation method.
    Hosai H; Yamanishi K; Ueda S; Minekawa Y; Ogino T
    Biken J; 1970 Jun; 13(2):121-6. PubMed ID: 4990327
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurovirulence of mumps virus: intraspinal inoculation test in marmosets.
    Saika S; Kidokoro M; Aoki A; Ohkawa T
    Biologicals; 2004 Sep; 32(3):147-52. PubMed ID: 15536045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurovirulence safety testing of mumps vaccines--historical perspective and current status.
    Rubin SA; Afzal MA
    Vaccine; 2011 Apr; 29(16):2850-5. PubMed ID: 21334386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological differences in the central nervous system and organs of monkeys inoculated intracerebrally with virulent and attenuated strains of mumps virus.
    Yuzepchuk SA; Rozina EE; Kaptsova TI; Kulish EA
    Acta Virol; 1975 Jul; 19(4):305-10. PubMed ID: 241228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monkey neurovirulence test for live mumps vaccine.
    Maximova O; Dragunsky E; Taffs R; Snoy P; Cogan J; Marsden S; Levenbook I
    Biologicals; 1996 Sep; 24(3):223-4. PubMed ID: 8978921
    [No Abstract]   [Full Text] [Related]  

  • 14. [The quality and efficacy of a Russian live mumps vaccine].
    Popov VF; Kaplunova OP; Iunasova TN
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):51-3. PubMed ID: 9245142
    [No Abstract]   [Full Text] [Related]  

  • 15. The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study.
    Rubin SA; Afzal MA; Powell CL; Bentley ML; Auda GR; Taffs RE; Carbone KM
    J Infect Dis; 2005 Apr; 191(7):1123-8. PubMed ID: 15747248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype.
    Rubin SA; Amexis G; Pletnikov M; Li Z; Vanderzanden J; Mauldin J; Sauder C; Malik T; Chumakov K; Carbone KM
    J Virol; 2003 Nov; 77(21):11616-24. PubMed ID: 14557647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative evaluation of neurovirulence of domestic and foreign live mumps vaccine].
    Maksimova OA; Popov VF; Bektimirov TA; Grigor'eva LV; Iunasova TN; Kaplunova OP; Sharova OK
    Vopr Virusol; 2001; 46(5):31-5. PubMed ID: 11715706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of live mumps virus vaccines.
    Furesz J
    J Med Virol; 2002 Jul; 67(3):299-300. PubMed ID: 12116018
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain.
    Rubin SA; Pletnikov M; Carbone KM
    J Virol; 1998 Oct; 72(10):8037-42. PubMed ID: 9733843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biology of attenuated mumps, rubella, measles and rabies viruses. Comparative considerations on the methods of attenuation of their virulence].
    Ciaccio G
    Riv Biol; 1970; 63(1):87-129. PubMed ID: 4996066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.